Genmab | GEN - Kapitał Własny I Rezerwy





Kapitał Własny I Rezerwy Zmiana Data
Agios Pharmaceuticals USD 1.11B 84M 2026-03
Almirall EUR 1.53B 43.26M 2026-06
Amarin USD 443.62M 5.8M 2026-06
Amgen USD 9.19B 532M 2026-03
argenx SE USD 8.42B 1.09B 2026-06
AstraZeneca USD 50.3B 2.96B 2026-06
Bayer EUR 28.85B 2.9B 2026-03
BioMarin Pharmaceutical USD 6.21B 125.11M 2026-03
Demant DKK 9.84B 446M 2025-12
Exelixis USD 1.94B 225.57M 2026-03
Fresenius Medical Care EUR 14.2B 13.95B 2026-03
Genmab DKK 5.85B 96M 2025-12
GlaxoSmithKline GBP 17.64B 223M 2026-06
GN Store Nord DKK 10.12B 4.76B 2026-03
GRIFOLS EUR 5.46B 171M 2026-03
Hikma Pharmaceutical USD 2.59B 42M 2025-12
Insmed USD 704.85M 34.12M 2026-03
Lakefront Biotherapeutics EUR 3.25B 17.5M 2026-03
Lonza CHF 9.13B 513M 2025-12
Merck EUR 29.74B 1.15B 2026-03
Novartis USD 41.95B 3.02B 2026-06
Regeneron Pharmaceuticals USD 31.42B 166.7M 2026-03
Roche Holding CHF 32.69B 1.11B 2026-06
Sanofi EUR 72.81B 1.1B 2026-03
UCB EUR 10.87B 1.18B 2025-12